About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.

Cold and flu season is here to start 2025. But simple steps can help protect you and your family - In the winter months, it ...

There’s no medication for norovirus. Instead, you’ll need to rehydrate as much as possible with water and other liquids. Seek ...

Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...

Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.

Respiratory diseases are on the rise in Oneida County and beyond. The county has provided tips to keep you and your family ...

NanoViricides, Inc. (NYSE American: NNVC) announced significant progress on NV-387, a broad-spectrum antiviral demonstrating superior efficacy in an ...

The S&P 500 Index ($SPX) dazzled investors in 2024, soaring over 20% for the second consecutive year. This extraordinary ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...